Launch of 'To Immunity and Beyond' podcast series

Lower-dose yellow fever vaccine as effective as the current standard

In a recent study, researchers at the KEMRI Wellcome Trust Research Programme in Kenya have discovered that a low-dose of the yellow fever vaccine is as effective as the current standard dose.

Pancreatic cancer immune map provides clues for precision treatment targeting

Study shows why there are differences in prognosis between different pancreatic tumours and identifies potential avenues for improved treatment approaches.

Bangladesh malaria vaccine and drug administration trial begins

After more than a year of community engagement and preparation in 100 villages with over 12,000 inhabitants across the Chittagong Hill Tracts, a mass malaria vaccine (R21/Matrix M) and drug administration (DHA, piperaquine, and single low dose primaquine) study was launched on 15 February.

Immune response may be harnessed to control HIV